Abcombi representatives completed the February-March

   2017 I-Corps at NIH program in which we refined the

   company’s strategy for our influenza therapeutic.

   Abcombi took home $50,000 during at the conclusion

   of the Critical Path Accelerator Program

   Abcombi has been announced as a 2016 Finalist for

   the 43North Business Plan Competition.

   Abcombi Biosciences pitched at the Bright Buffalo

   Niagara Entrepreneur Expo and took home the

   grand prize of $20,000.